Back to mobile site

BMO Capital on Zimmer Biomet (ZBH): 'Sizing ZBH's Japan Iodine-Coated Hip Opportunity'

September 28, 2026 9:30 AM EDT Send to a Friend
BMO Capital analyst Vik Chopra reiterated a Market Perform rating and $96.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login